No Data
No Data
Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?
Here's How Much $100 Invested In Insulet 15 Years Ago Would Be Worth Today
Insulet (NASDAQ:PODD) has outperformed the market over the past 15 years by 12.41% on an annualized basis producing an average annual return of 25.12%. Currently, Insulet has a market capitalization
Glaukos Cut as Citi Reviews U.S. MedTechs
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod brand of products, today announced plans to release its financial results for the
(PODD) - Analyzing Insulet's Short Interest
Insulet's (NYSE:PODD) short percent of float has fallen 9.44% since its last report. The company recently reported that it has 2.71 million shares sold short, which is 5.18% of all regular shares that
Why Insulet Corporation (NASDAQ:PODD) Looks Like A Quality Company
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). By way of learni
No Data